Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€86.75
14.10.22
-
14.11.22
0.58%
15.11.22

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€68.85
14.10.22
-
14.10.23
-23.31%
08.02.23

buy
Serviceware SE

Start price
Target price
Perf. (%)
€6.92
14.10.22
-
14.10.23
-1.45%
15.10.22

buy
Zscaler Inc

Start price
Target price
Perf. (%)
€146.96
14.10.22
-
14.10.23
9.81%
14.10.23

buy
Workday, Inc.

Start price
Target price
Perf. (%)
€145.98
14.10.22
-
14.10.23
40.67%
14.10.23

buy
ServiceNow Inc.

Start price
Target price
Perf. (%)
€372.75
14.10.22
-
14.10.23
39.72%
14.10.23

buy
Salesforce.com

Start price
Target price
Perf. (%)
€149.00
14.10.22
-
14.10.23
30.81%
14.10.23

buy
Arista Networks

Start price
Target price
Perf. (%)
€106.30
14.10.22
-
14.10.23
70.51%
14.10.23

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€137.82
13.10.22
-
13.10.23
5.79%
23.02.23

Significant cyclical dependencies
Higher risks for its business
buy
Vonovia SE

Start price
Target price
Perf. (%)
€19.03
13.10.22
€35.00
13.10.23
19.47%
13.10.23

buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€4.98
13.10.22
-
13.10.23
-18.27%
14.10.23

Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.55
13.10.22
€2.30
13.10.23
42.55%
19.11.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
iBio Inc.

Start price
Target price
Perf. (%)
€1.50
13.10.22
€0.10
13.10.23
-21.39%
27.02.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Applied Materials Inc.

Start price
Target price
Perf. (%)
€80.66
13.10.22
€140.00
13.10.23
66.23%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€21.36
13.10.22
€20.00
13.10.23
-48.44%
11.01.23

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Columbia Care Inc.

Start price
Target price
Perf. (%)
€1.59
13.10.22
€1.90
13.10.23
-54.52%
11.01.23

Capable Management
Innovative
Bad rating
Few uniques
buy
Carbios S.A.

Start price
Target price
Perf. (%)
€23.36
13.10.22
€30.60
20.09.23
0.17%
21.09.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Verizon Communications Inc.

Start price
Target price
Perf. (%)
€36.50
13.10.22
-
13.10.23
-20.14%
14.10.23

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€39.30
13.10.22
-
13.10.23
-0.71%
14.10.23

buy
Ströer SE

Start price
Target price
Perf. (%)
€41.48
13.10.22
-
13.10.23
4.10%
14.10.23

buy
Bijou Brigitte

Start price
Target price
Perf. (%)
€33.30
13.10.22
€35.00
13.10.23
4.50%
17.10.22

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€139.70
13.10.22
-
13.10.23
-31.54%
14.10.23

buy
Siemens Energy AG

Start price
Target price
Perf. (%)
€10.70
13.10.22
€15.00
13.10.23
-3.23%
13.10.22

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
buy
Under Armour Inc. A

Start price
Target price
Perf. (%)
€7.99
13.10.22
€11.00
13.10.23
-
13.10.22

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€67.38
13.10.22
€46.00
13.10.23
9.44%
14.10.23

Top 10 in its market
Good rating
Medium risks for its business
Bad culture